Literature DB >> 19592578

Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice.

Roman Szabo1, John P Hobson, Kristina Christoph, Peter Kosa, Karin List, Thomas H Bugge.   

Abstract

Hypomorphic mutations in the human SPINT2 gene cause a broad spectrum of abnormalities in organogenesis, including organ and digit duplications, atresia, fistulas, hypertelorism, cleft palate and hamartoma. SPINT2 encodes the transmembrane serine protease inhibitor HAI2 (placental bikunin), and the severe developmental effects of decreased HAI2 activity can be hypothesized to be a consequence of excess pericellular proteolytic activity. Indeed, we show here that HAI2 is a potent regulator of protease-guided cellular responses, including motogenic activity and transepithelial resistance of epithelial monolayers. Furthermore, we show that inhibition of the transmembrane serine protease matriptase (encoded by St14) is an essential function of HAI2 during tissue morphogenesis. Genetic inactivation of the mouse Spint2 gene led to defects in neural tube closure, abnormal placental labyrinth development associated with loss of epithelial cell polarity, and embryonic demise. Developmental defects observed in HAI2-deficient mice were caused by unregulated matriptase activity, as both placental development and embryonic survival in HAI2-deficient embryos were completely restored by the simultaneous genetic inactivation of matriptase. However, neural tube defects were detected in HAI2-deficient mice even in the absence of matriptase, although at lower frequency, indicating that the inhibition of additional serine protease(s) by HAI2 is required to complete neural development. Finally, by genetic complementation analysis, we uncovered a unique and complex functional interaction between HAI2 and the related HAI1 in the regulation of matriptase activity during development. This study indicates that unregulated matriptase-dependent cell surface proteolysis can cause a diverse array of abnormalities in mammalian development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19592578      PMCID: PMC2709071          DOI: 10.1242/dev.038430

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  62 in total

1.  Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates.

Authors:  T Takeuchi; J L Harris; W Huang; K W Yan; S R Coughlin; C S Craik
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

2.  Camostat attenuates airway epithelial sodium channel function in vivo through the inhibition of a channel-activating protease.

Authors:  K Coote; H C Atherton-Watson; R Sugar; A Young; A MacKenzie-Beevor; M Gosling; G Bhalay; G Bloomfield; A Dunstan; R J Bridges; J R Sabater; W M Abraham; D Tully; R Pacoma; A Schumacher; J Harris; H Danahay
Journal:  J Pharmacol Exp Ther       Date:  2009-02-03       Impact factor: 4.030

3.  A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer.

Authors:  C Wallrapp; S Hähnel; F Müller-Pillasch; B Burghardt; T Iwamura; M Ruthenbürger; M M Lerch; G Adler; T M Gress
Journal:  Cancer Res       Date:  2000-05-15       Impact factor: 12.701

4.  The Caenorhabditis elegans spe-6 gene is required for major sperm protein assembly and shows second site non-complementation with an unlinked deficiency.

Authors:  J P Varkey; P L Jansma; A N Minniti; S Ward
Journal:  Genetics       Date:  1993-01       Impact factor: 4.562

5.  Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease.

Authors:  S L Lee; R B Dickson; C Y Lin
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

6.  Proteolytic conversion of single chain precursor macrophage-stimulating protein to a biologically active heterodimer by contact enzymes of the coagulation cascade.

Authors:  M H Wang; T Yoshimura; A Skeel; E J Leonard
Journal:  J Biol Chem       Date:  1994-02-04       Impact factor: 5.157

7.  Activation of the zymogen of hepatocyte growth factor activator by thrombin.

Authors:  T Shimomura; J Kondo; M Ochiai; D Naka; K Miyazawa; Y Morimoto; N Kitamura
Journal:  J Biol Chem       Date:  1993-10-25       Impact factor: 5.157

8.  Interacting proteins identified by genetic interactions: a missense mutation in alpha-tubulin fails to complement alleles of the testis-specific beta-tubulin gene of Drosophila melanogaster.

Authors:  T S Hays; R Deuring; B Robertson; M Prout; M T Fuller
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

9.  Purification and characterization of hepatocyte growth factor (HGF)-converting enzyme: activation of pro-HGF.

Authors:  K Mizuno; Y Tanoue; I Okano; T Harano; K Takada; T Nakamura
Journal:  Biochem Biophys Res Commun       Date:  1994-02-15       Impact factor: 3.575

10.  Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor.

Authors:  L Naldini; L Tamagnone; E Vigna; M Sachs; G Hartmann; W Birchmeier; Y Daikuhara; H Tsubouchi; F Blasi; P M Comoglio
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more
  56 in total

Review 1.  Protease-activated receptor 2 signaling in inflammation.

Authors:  Andrea S Rothmeier; Wolfram Ruf
Journal:  Semin Immunopathol       Date:  2011-10-06       Impact factor: 9.623

2.  Endogenous expression of matriptase in neural progenitor cells promotes cell migration and neuron differentiation.

Authors:  Jung-Da Fang; Hsiao-Chin Chou; Hsiu-Hui Tung; Pao-Yi Huang; Sheau-Ling Lee
Journal:  J Biol Chem       Date:  2010-12-13       Impact factor: 5.157

Review 3.  The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment.

Authors:  Toni M Antalis; Marguerite S Buzza; Kathryn M Hodge; John D Hooper; Sarah Netzel-Arnett
Journal:  Biochem J       Date:  2010-06-15       Impact factor: 3.857

4.  HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase.

Authors:  C-H Tsai; C-H Teng; Y-T Tu; T-S Cheng; S-R Wu; C-J Ko; H-Y Shyu; S-W Lan; H-P Huang; S-F Tzeng; M D Johnson; C-Y Lin; P-W Hsiao; M-S Lee
Journal:  Oncogene       Date:  2013-10-14       Impact factor: 9.867

5.  Mesotrypsin Has Evolved Four Unique Residues to Cleave Trypsin Inhibitors as Substrates.

Authors:  Alexandre P Alloy; Olumide Kayode; Ruiying Wang; Alexandra Hockla; Alexei S Soares; Evette S Radisky
Journal:  J Biol Chem       Date:  2015-07-14       Impact factor: 5.157

6.  Blocking the proteolytic activity of zymogen matriptase with antibody-based inhibitors.

Authors:  Trine Tamberg; Zebin Hong; Daphné De Schepper; Signe Skovbjerg; Daniel M Dupont; Lars Vitved; Christine R Schar; Karsten Skjoedt; Lotte K Vogel; Jan K Jensen
Journal:  J Biol Chem       Date:  2018-11-08       Impact factor: 5.157

Review 7.  Membrane-anchored serine proteases in vertebrate cell and developmental biology.

Authors:  Roman Szabo; Thomas H Bugge
Journal:  Annu Rev Cell Dev Biol       Date:  2011-06-29       Impact factor: 13.827

Review 8.  Urinary serine proteases and activation of ENaC in kidney--implications for physiological renal salt handling and hypertensive disorders with albuminuria.

Authors:  Per Svenningsen; Henrik Andersen; Lise H Nielsen; Boye L Jensen
Journal:  Pflugers Arch       Date:  2014-12-09       Impact factor: 3.657

9.  The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.

Authors:  Stine Friis; Katiuchia Uzzun Sales; Jeffrey Martin Schafer; Lotte K Vogel; Hiroaki Kataoka; Thomas H Bugge
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

10.  A matriptase-prostasin reciprocal zymogen activation complex with unique features: prostasin as a non-enzymatic co-factor for matriptase activation.

Authors:  Stine Friis; Katiuchia Uzzun Sales; Sine Godiksen; Diane E Peters; Chen-Yong Lin; Lotte K Vogel; Thomas H Bugge
Journal:  J Biol Chem       Date:  2013-05-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.